CD4 and HIV-1 infection: Although this study was limited by the relatively low percentage of individuals who were co-infected with schistosomiasis and HIV-1, the results indicate that HIV-1 infection per se or its moderate immunosuppressive effects, as indicated by the CD4+ T cell counts, does not significantly affect praziquantel efficacy in terms of cure rate or reduction in the intensity of infection.